{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,5,27]],"date-time":"2026-05-27T12:09:40Z","timestamp":1779883780939,"version":"3.53.1"},"reference-count":35,"publisher":"American Society of Hematology","issue":"12","content-domain":{"domain":["ashpublications.org"],"crossmark-restriction":true},"short-container-title":[],"published-print":{"date-parts":[[2023,6,27]]},"abstract":"<jats:title>Abstract<\/jats:title>\n               <jats:p>There is limited information regarding COVID-19 in long-term blood or marrow transplant (BMT) survivors. We leveraged the BMT Survivor Study (BMTSS) to address this gap. BMTSS included patients who underwent BMT at 1 of 3 sites in the United States between 1974 and 2014 and survived \u22652 years after BMT. A sibling cohort serves as a non-BMT comparison group. Participants (2430 BMT survivors; 780 non-BMT participants) completed the BMTSS survey between October 2020 and November 2021 about COVID-19 testing, risk mitigation behaviors, morbidity, and health care use. Median age at BMT was 46 years (range, 0-78 years) and median follow-up since BMT was 14 years (6-46 years); 76% were non-Hispanic White, 54% had received allogeneic BMT. The risk of COVID-19 infection was comparable for BMT survivors vs non-BMT participants (15-month cumulative incidence, 6.5% vs 8.1%; adjusted odd ratio [aOR]\u00a0= 0.93; 95% confidence interval [CI], 0.65-1.33; P\u00a0= .68). Among survivors, being unemployed (aOR 1.90; 95%\u00a0CI, 1.12-3.23; P\u00a0= .02; reference: retired) increased the odds of infection; always wearing a mask in public was protective (aOR\u00a0= 0.49; 95%\u00a0CI, 0.31-0.77; P\u00a0= .002; reference: not always masking). When compared with COVID-positive non-BMT participants, COVID-positive BMT survivors had higher odds of hospitalization (aOR\u00a0= 2.23; 95%\u00a0CI, 0.99-5.05; P\u00a0= .05); however, the odds of emergency department visits were comparable (aOR\u00a0= 1.60; 95%\u00a0CI\u00a0= 0.71-3.58; P\u00a0= .25). COVID-19 infection status did not increase the odds of hospitalization among BMT survivors (aOR\u00a0=\u00a01.32; 95%\u00a0CI\u00a0= 0.89-1.95; P\u00a0= .17) but did increase the odds of emergency department visits (aOR\u00a0= 2.63; 95%\u00a0CI, 1.74-3.98; P &amp;lt;.0001). These findings inform health care providers about the management of care for long-term BMT survivors during the ongoing pandemic.<\/jats:p>","DOI":"10.1182\/bloodadvances.2022009550","type":"journal-article","created":{"date-parts":[[2023,2,1]],"date-time":"2023-02-01T22:44:37Z","timestamp":1675291477000},"page":"2843-2854","update-policy":"https:\/\/doi.org\/10.1182\/blood.2019cm0000","source":"Crossref","is-referenced-by-count":2,"title":["Risk of COVID-19 infection in long-term survivors of blood or marrow transplantation: a BMTSS report"],"prefix":"10.1182","volume":"7","author":[{"ORCID":"https:\/\/orcid.org\/0000-0001-9126-2169","authenticated-orcid":false,"given":"Emily E.","family":"Johnston","sequence":"first","affiliation":[{"name":"1Institute for Cancer Outcomes and Survivorship, University of Alabama at Birmingham, Birmingham, AL"},{"name":"2Division of Pediatric Hematology-Oncology, Department of Pediatrics, University of Alabama at Birmingham, Birmingham, AL"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Qingrui","family":"Meng","sequence":"additional","affiliation":[{"name":"1Institute for Cancer Outcomes and Survivorship, University of Alabama at Birmingham, Birmingham, AL"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Lindsey","family":"Hageman","sequence":"additional","affiliation":[{"name":"1Institute for Cancer Outcomes and Survivorship, University of Alabama at Birmingham, Birmingham, AL"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Jessica","family":"Wu","sequence":"additional","affiliation":[{"name":"1Institute for Cancer Outcomes and Survivorship, University of Alabama at Birmingham, Birmingham, AL"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Elizabeth","family":"Ross","sequence":"additional","affiliation":[{"name":"1Institute for Cancer Outcomes and Survivorship, University of Alabama at Birmingham, Birmingham, AL"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Shawn","family":"Lim","sequence":"additional","affiliation":[{"name":"1Institute for Cancer Outcomes and Survivorship, University of Alabama at Birmingham, Birmingham, AL"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Nora","family":"Balas","sequence":"additional","affiliation":[{"name":"1Institute for Cancer Outcomes and Survivorship, University of Alabama at Birmingham, Birmingham, AL"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-0662-5699","authenticated-orcid":false,"given":"Alysia","family":"Bosworth","sequence":"additional","affiliation":[{"name":"3Department of Population Sciences, City of Hope, Duarte, CA"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Hok Sreng","family":"Te","sequence":"additional","affiliation":[{"name":"4Division of Hematology, Oncology and Transplantation, University of Minnesota, Minneapolis, MN"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Liton","family":"Francisco","sequence":"additional","affiliation":[{"name":"1Institute for Cancer Outcomes and Survivorship, University of Alabama at Birmingham, Birmingham, AL"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0001-5740-2316","authenticated-orcid":false,"given":"Ravi","family":"Bhatia","sequence":"additional","affiliation":[{"name":"5Division of Hematology, Oncology and Bone Marrow Transplantation, University of Alabama at Birmingham, Birmingham, AL"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Stephen J.","family":"Forman","sequence":"additional","affiliation":[{"name":"6Department of Hematology & Hematopoietic Cell Transplantation, City of Hope, Duarte, CA"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"F. Lennie","family":"Wong","sequence":"additional","affiliation":[{"name":"3Department of Population Sciences, City of Hope, Duarte, CA"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0003-2604-8603","authenticated-orcid":false,"given":"Saro H.","family":"Armenian","sequence":"additional","affiliation":[{"name":"3Department of Population Sciences, City of Hope, Duarte, CA"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0001-8078-8579","authenticated-orcid":false,"given":"Daniel J.","family":"Weisdorf","sequence":"additional","affiliation":[{"name":"4Division of Hematology, Oncology and Transplantation, University of Minnesota, Minneapolis, MN"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0003-3319-5652","authenticated-orcid":false,"given":"Wendy","family":"Landier","sequence":"additional","affiliation":[{"name":"1Institute for Cancer Outcomes and Survivorship, University of Alabama at Birmingham, Birmingham, AL"},{"name":"2Division of Pediatric Hematology-Oncology, Department of Pediatrics, University of Alabama at Birmingham, Birmingham, AL"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-7755-5683","authenticated-orcid":false,"given":"Smita","family":"Bhatia","sequence":"additional","affiliation":[{"name":"1Institute for Cancer Outcomes and Survivorship, University of Alabama at Birmingham, Birmingham, AL"},{"name":"2Division of Pediatric Hematology-Oncology, Department of Pediatrics, University of Alabama at Birmingham, Birmingham, AL"}],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"234","published-online":{"date-parts":[[2023,6,16]]},"reference":[{"key":"2023062614232662600_bib1","unstructured":"Johns Hopkins University & Medicine Coronavirus Resource Center. COVID-19 United States cases by county. 2023. Accessed 29 December 2020. https:\/\/coronavirus.jhu.edu\/us-map."},{"key":"2023062614232662600_bib2","unstructured":"Centers for Disease Control and Prevention\n          . Science Brief: indicators for monitoring COVID-19 community levels and making public health recommendations. 2022. Accessed 25 May 2022. https:\/\/www.cdc.gov\/coronavirus\/2019-ncov\/science\/science-briefs\/indicators-monitoring-community-levels.html."},{"issue":"34","key":"2023062614232662600_bib3","doi-asserted-by":"crossref","first-page":"3778","DOI":"10.1200\/JCO.21.00702","article-title":"SARS-CoV-2 in childhood cancer in 2020: a disease of disparities","volume":"39","author":"Johnston","year":"2021","journal-title":"J\u00a0Clin Oncol"},{"issue":"10","key":"2023062614232662600_bib4","doi-asserted-by":"crossref","first-page":"1416","DOI":"10.1016\/S1470-2045(21)00454-X","article-title":"Global characteristics and outcomes of SARS-CoV-2 infection in children and adolescents with cancer (GRCCC): a cohort study","volume":"22","author":"Mukkada","year":"2021","journal-title":"Lancet Oncol"},{"issue":"1","key":"2023062614232662600_bib5","doi-asserted-by":"crossref","first-page":"69","DOI":"10.1001\/jamaoncol.2021.5148","article-title":"Evaluation of COVID-19 mortality and adverse outcomes in US Patients with or without cancer","volume":"8","author":"Chavez-MacGregor","year":"2022","journal-title":"JAMA Oncol"},{"issue":"3","key":"2023062614232662600_bib6","doi-asserted-by":"crossref","first-page":"335","DOI":"10.1016\/S1470-2045(20)30096-6","article-title":"Cancer patients in SARS-CoV-2 infection: a nationwide analysis in China","volume":"21","author":"Liang","year":"2020","journal-title":"Lancet Oncol"},{"key":"2023062614232662600_bib7","unstructured":"National Cancer Institute. COVID-19: what people with cancer should know. 2020. Accessed 25 May 2022. https:\/\/www.cancer.gov\/about-cancer\/coronavirus\/coronavirus-cancer-patient-information."},{"issue":"3","key":"2023062614232662600_bib8","doi-asserted-by":"crossref","first-page":"e185","DOI":"10.1016\/S2352-3026(20)30429-4","article-title":"Clinical characteristics and outcomes of COVID-19 in haematopoietic stem-cell transplantation recipients: an observational cohort study","volume":"8","author":"Sharma","year":"2021","journal-title":"Lancet Haematol"},{"issue":"3","key":"2023062614232662600_bib9","doi-asserted-by":"crossref","first-page":"e28857","DOI":"10.1002\/pbc.28857","article-title":"COVID-19 in pediatric survivors of childhood cancer and hematopoietic cell transplantation from a single center in New York city","volume":"68","author":"Jimenez-Kurlander","year":"2021","journal-title":"Pediatr Blood Cancer"},{"issue":"12","key":"2023062614232662600_bib10","doi-asserted-by":"crossref","first-page":"1281","DOI":"10.1200\/JCO.21.02592","article-title":"Risk of COVID-19 infections and of severe complications among survivors of childhood, adolescent, and young adult cancer: a population-based study in Ontario, Canada","volume":"40","author":"Gupta","year":"2022","journal-title":"J\u00a0Clin Oncol"},{"issue":"10","key":"2023062614232662600_bib11","doi-asserted-by":"crossref","first-page":"696.e1","DOI":"10.1016\/j.jtct.2022.06.026","article-title":"Clinical characteristics and outcomes of COVID-19 in pediatric and early adolescent and young adult hematopoietic stem cell transplant recipients: a cohort study","volume":"28","author":"Bhatt","year":"2022","journal-title":"Transplant Cell Ther"},{"issue":"2","key":"2023062614232662600_bib12","doi-asserted-by":"crossref","first-page":"e13792","DOI":"10.1111\/tid.13792","article-title":"Impact of COVID-19 in hematopoietic stem cell transplant recipients: A systematic review and meta-analysis","volume":"24","author":"Shahzad","year":"2022","journal-title":"Transpl Infect Dis"},{"issue":"6","key":"2023062614232662600_bib13","doi-asserted-by":"crossref","first-page":"783","DOI":"10.1158\/2159-8290.CD-20-0422","article-title":"Patients with cancer appear more vulnerable to SARS-CoV-2: a multicenter study during the COVID-19 outbreak","volume":"10","author":"Dai","year":"2020","journal-title":"Cancer Discov"},{"issue":"5","key":"2023062614232662600_bib14","doi-asserted-by":"crossref","first-page":"277","DOI":"10.1038\/s41577-020-00457-z","article-title":"T\u00a0cell regeneration after immunological injury","volume":"21","author":"Velardi","year":"2021","journal-title":"Nat Rev Immunol"},{"key":"2023062614232662600_bib15","author":"Champlin","year":"2003","edition":"6th edition"},{"issue":"9","key":"2023062614232662600_bib16","doi-asserted-by":"crossref","first-page":"1227","DOI":"10.1038\/bmt.2015.133","article-title":"Quantitative characterization of T-cell repertoire in allogeneic hematopoietic stem cell transplant recipients","volume":"50","author":"Yew","year":"2015","journal-title":"Bone Marrow Transplant"},{"issue":"7","key":"2023062614232662600_bib17","doi-asserted-by":"crossref","first-page":"1073","DOI":"10.1016\/j.bbmt.2013.04.002","article-title":"Burden of morbidity in 10+ year survivors of hematopoietic cell transplantation: report from the bone marrow transplantation survivor study","volume":"19","author":"Sun","year":"2013","journal-title":"Biol Blood Marrow Transplant"},{"issue":"17","key":"2023062614232662600_bib18","doi-asserted-by":"crossref","first-page":"3129","DOI":"10.1182\/blood-2009-06-229369","article-title":"Prevalence and predictors of chronic health conditions after hematopoietic cell transplantation: a report from the bone marrow transplant survivor study","volume":"116","author":"Sun","year":"2010","journal-title":"Blood"},{"issue":"10","key":"2023062614232662600_bib19","doi-asserted-by":"crossref","first-page":"1498","DOI":"10.1016\/j.bbmt.2013.07.020","article-title":"Prevalence of hematopoietic cell transplant survivors in the United States","volume":"19","author":"Majhail","year":"2013","journal-title":"Biol Blood Marrow Transplant"},{"issue":"11","key":"2023062614232662600_bib20","doi-asserted-by":"crossref","first-page":"1191","DOI":"10.1038\/sj.bmt.1702419","article-title":"Validation of self-reported complications by bone marrow transplantation survivors","volume":"25","author":"Louie","year":"2000","journal-title":"Bone Marrow Transplant"},{"issue":"2","key":"2023062614232662600_bib21","doi-asserted-by":"crossref","first-page":"220","DOI":"10.1001\/jamaoncol.2020.6178","article-title":"Analyses of risk, racial disparity, and outcomes among US patients with cancer and COVID-19 infection","volume":"7","author":"Wang","year":"2021","journal-title":"JAMA Oncol"},{"issue":"6","key":"2023062614232662600_bib22","doi-asserted-by":"crossref","first-page":"691","DOI":"10.1093\/jnci\/djaa159","article-title":"Prevalence and outcome of COVID-19 infection in cancer patients: a national veterans affairs study","volume":"113","author":"Fillmore","year":"2020","journal-title":"J\u00a0Natl Cancer Inst"},{"issue":"10242","key":"2023062614232662600_bib23","doi-asserted-by":"crossref","first-page":"1973","DOI":"10.1016\/S0140-6736(20)31142-9","article-title":"Physical distancing, face masks, and eye protection to prevent person-to-person transmission of SARS-CoV-2 and COVID-19: a systematic review and meta-analysis","volume":"395","author":"Chu","year":"2020","journal-title":"Lancet"},{"issue":"2","key":"2023062614232662600_bib24","doi-asserted-by":"crossref","first-page":"176","DOI":"10.1001\/jamapediatrics.2020.5052","article-title":"Assessment of 135 794 pediatric patients tested for severe acute respiratory syndrome coronavirus 2 across the United States","volume":"175","author":"Bailey","year":"2021","journal-title":"JAMA Pediatr"},{"issue":"3","key":"2023062614232662600_bib25","doi-asserted-by":"crossref","first-page":"362","DOI":"10.7326\/M20-6306","article-title":"Racial and ethnic disparities in COVID-19\u2013related infections, hospitalizations, and deaths","volume":"174","author":"Mackey","year":"2021","journal-title":"Ann Intern Med"},{"issue":"8","key":"2023062614232662600_bib26","doi-asserted-by":"crossref","first-page":"e039849","DOI":"10.1136\/bmjopen-2020-039849","article-title":"Racial and ethnic disparities in SARS-CoV-2 pandemic: analysis of a COVID-19 observational registry for a diverse US metropolitan population","volume":"10","author":"Vahidy","year":"2020","journal-title":"BMJ Open"},{"issue":"36","key":"2023062614232662600_bib27","doi-asserted-by":"crossref","first-page":"1250","DOI":"10.15585\/mmwr.mm6936a4","article-title":"Delay or avoidance of medical care because of COVID-19\u2013related concerns \u2014 United States, June 2020","volume":"69","author":"Czeisler","year":"2020","journal-title":"MMWR Morb Mortal Wkly Rep"},{"issue":"5","key":"2023062614232662600_bib28","doi-asserted-by":"crossref","first-page":"1314","DOI":"10.1111\/jgs.17722","article-title":"Risk from delayed or missed care and non-COVID-19 outcomes for older patients with chronic conditions during the pandemic","volume":"70","author":"Smith","year":"2022","journal-title":"J\u00a0Am Geriatr Soc"},{"issue":"3","key":"2023062614232662600_bib29","doi-asserted-by":"crossref","first-page":"e221754","DOI":"10.1001\/jamanetworkopen.2022.1754","article-title":"Hospitalizations and mortality from non-SARS-CoV-2 causes among medicare beneficiaries at US hospitals during the SARS-CoV-2 pandemic","volume":"5","author":"Dang","year":"2022","journal-title":"JAMA Netw Open"},{"issue":"3","key":"2023062614232662600_bib30","doi-asserted-by":"crossref","first-page":"347","DOI":"10.1080\/07347332.2021.1888184","article-title":"Cancer survivor worries about treatment disruption and detrimental health outcomes due to the COVID-19 pandemic","volume":"39","author":"Leach","year":"2021","journal-title":"J\u00a0Psychosoc Oncol"},{"issue":"11","key":"2023062614232662600_bib31","doi-asserted-by":"crossref","first-page":"737","DOI":"10.1016\/j.jtct.2022.07.020","article-title":"Secondary impact of the coronavirus disease 19 pandemic on patients and the cellular therapy healthcare ecosystem","volume":"28","author":"Koo","year":"2022","journal-title":"Transplant Cell Ther"},{"issue":"15_suppl","key":"2023062614232662600_bib32","doi-asserted-by":"crossref","DOI":"10.1200\/JCO.2021.39.15_suppl.e13615","article-title":"Telehealth to increase access to transplant survivorship care for allogeneic stem cell transplant recipients regardless of distance to transplant center or neighborhood income","volume":"39","author":"Ahmed","year":"2021","journal-title":"J\u00a0Clin Oncol"},{"issue":"13","key":"2023062614232662600_bib33","doi-asserted-by":"crossref","first-page":"1414","DOI":"10.1200\/JCO.21.02419","article-title":"Risk and outcome of breakthrough COVID-19 infections in vaccinated patients with cancer: real-world evidence from the national COVID cohort collaborative","volume":"40","author":"Song","year":"2022","journal-title":"J\u00a0Clin Oncol"},{"issue":"1","key":"2023062614232662600_bib34","doi-asserted-by":"crossref","first-page":"1436","DOI":"10.1186\/s12889-022-13819-0","article-title":"A systematic review of observational methods used to quantify personal protective behaviours among members of the public during the COVID-19 pandemic, and the concordance between observational and self-report measures in infectious disease health protection","volume":"22","author":"Davies","year":"2022","journal-title":"BMC Public Health"},{"issue":"4","key":"2023062614232662600_bib35","doi-asserted-by":"crossref","first-page":"2025","DOI":"10.1007\/s11135-011-9640-9","article-title":"Determinants of social desirability bias in sensitive surveys: a literature review","volume":"47","author":"Krumpal","year":"2013","journal-title":"Qual Quant"}],"container-title":["Blood Advances"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/ashpublications.org\/bloodadvances\/article-pdf\/7\/12\/2843\/2060015\/blooda_adv-2022-009550-main.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"syndication"},{"URL":"https:\/\/ashpublications.org\/bloodadvances\/article-pdf\/7\/12\/2843\/2060015\/blooda_adv-2022-009550-main.pdf","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2023,6,26]],"date-time":"2023-06-26T14:24:47Z","timestamp":1687789487000},"score":1,"resource":{"primary":{"URL":"https:\/\/ashpublications.org\/bloodadvances\/article\/7\/12\/2843\/494291\/Risk-of-COVID-19-infection-in-long-term-survivors"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2023,6,16]]},"references-count":35,"journal-issue":{"issue":"12","published-print":{"date-parts":[[2023,6,27]]}},"URL":"https:\/\/doi.org\/10.1182\/bloodadvances.2022009550","relation":{},"ISSN":["2473-9529","2473-9537"],"issn-type":[{"value":"2473-9529","type":"print"},{"value":"2473-9537","type":"electronic"}],"subject":[],"published":{"date-parts":[[2023,6,16]]}}}